AstraZeneca Pauses Vaccine Trial for Safety Review
The pharmaceutical company AstraZeneca halted large, late-stage global trials of its coronavirus vaccine on Tuesday because of a serious suspected adverse reaction in a participant, the company said. It is not yet known whether the reaction was directly caused by the company’s vaccine or was coincidental. The pause, which was first reported by STAT, will…